First Approach for Aspirin Misuse Objective Screening

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 4, 2017

Primary Completion Date

April 10, 2017

Study Completion Date

April 10, 2017

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Laser speckle flowmetry

"A galvanic current (0.1 mA) will be applied between 2 patches on the forearm of patient and protocol was repeated at 4 minutes.~Microvascular response to current application (CIV) will be recorded by laser speckle flowmetry 10 minutes later.~Measurement of the value of skin blood flow (by laser speckle) at the stimulated area as compare to a non stimulated adjacent skin value taken as a reference Usual treatment will be recorded"

Trial Locations (1)

49100

UH Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT02997436 - First Approach for Aspirin Misuse Objective Screening | Biotech Hunter | Biotech Hunter